CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Brief Enhanced Anxiety Sensitivity Treatmentbehavioral
Likely dose
Single virtual face-to-face session of BEAST supplemented with mobile app for two weeksAI-extracted
Key inclusion· 3
  • English-speaking
  • Elevated anxiety sensitivity (SSASI score ≥9)
  • Functional impairment (WHODAS 2.0 score ≥5)
Key exclusion· 5
  • Cognitive impairment (Blessed Orientation-Memory-Concentration Test score ≥11)
  • No access to smartphone
  • Severe schizophrenia
  • Active psychotic or manic state

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05416203
NCT05416203N/ACompleted

Brief Enhanced Anxiety Sensitivity Treatment: A Pilot Study

VA Office of Research and Development·interventional·Posted Jun 13, 2022·Updated Jul 1, 2025

In Brief

A clinical study evaluating Brief Enhanced Anxiety Sensitivity Treatment for Anxiety Sensitivity and Functional Impairment. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This pilot study trial will test the acceptability, feasibility, and usability of a brief enhanced anxiety sensitivity treatment to reduce anxiety sensitivity and functional impairment in Veterans.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 13, 2022
Enrollment StartSep 1, 2022
Primary CompletionMay 31, 2024
Study CompletionAug 30, 2024
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.1 years ago

Interventions

Brief Enhanced Anxiety Sensitivity Treatmentbehavioral

BEAST is a CBT-based intervention that includes psychoeducation, identifying and challenging maladaptive thoughts, and interoceptive exposure. The intervention is delivered through a single virtual face-to-face session supplemented with a mobile app for two weeks after the face to face session.